Evidence map›Paper›PMID 12434017›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

The substrate binding domain of DnaK facilitates slow protein refolding.

Naoki Tanaka, Shota Nakao, Hiromasa Wadai, Shoichi Ikeda, Jean Chatellier, Shigeru Kunugi

Abstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naoki TanakaDepartment of Polymer Science and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo, Japan. tanaka@ipc.kit.ac.jp
Shota Nakao
Hiromasa Wadai
Shoichi Ikeda
Jean Chatellier
Shigeru Kunugi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined the effects of a fragment of the substrate binding domain of DnaK on protein refolding from chemically denatured states. The fragment DnaK384-638, containing a full-length substrate binding domain, tightly binds to the unfolded protein in solution. The effects of DnaK384-638 on the reactivation of beta-galactosidase and luciferase were examined at low substrate concentration and low temperature, conditions in which the folding is significantly slow (several days) but the reactivation yield is higher than those in ordinary refolding conditions. In the presence of DnaK384-638, the maximum yield of active beta-galactosidase was improved from 45% to 65% after a 48-h refolding reaction. Spectroscopic experiments showed that DnaK384-638 bound to partially structured monomers of beta-galactosidase and consequently suppressed aggregation. DnaK384-638 accelerated the refolding of luciferase to attain equilibrium in 8 h. On the other hand, DnaK386-561, which has no affinity for the substrate, had no chaperone activity for the reactivation of these proteins. These results indicate that the substrate binding of DnaK384-638 facilitates slow protein refolding.

Indexed as

Protein Foldingbeta-GalactosidaseBinding SitesEnzyme ActivationEscherichia coli ProteinsHSP70 Heat-Shock ProteinsKineticsLuciferasesModels, MolecularProtein BindingProtein DenaturationProtein Interaction MappingProtein Structure, TertiaryRecombinant Fusion ProteinsStructure-Activity RelationshipSubstrate Specificitybeta-GalactosidasednaK protein, E coliEscherichia coli ProteinsHSP70 Heat-Shock ProteinsLuciferasesRecombinant Fusion Proteins

Identifiers

PMID12434017
PMCPMC137728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.